Castle Biosciences' Deferred Taxes fell 9779.05% to $116000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year decrease of 31970.05%. This contributed to the annual value of $1.4 million for FY2024, which is 72825.11% up from last year.
Per Castle Biosciences' latest filing, its Deferred Taxes stood at $116000.0 for Q3 2025, which was down 9779.05% from -$4.7 million recorded in Q2 2025.
In the past 5 years, Castle Biosciences' Deferred Taxes ranged from a high of $5.2 million in Q3 2024 and a low of -$8.7 million during Q4 2021
Moreover, its 5-year median value for Deferred Taxes was -$503000.0 (2023), whereas its average is -$1.2 million.
Per our database at Business Quant, Castle Biosciences' Deferred Taxes surged by 9956.5% in 2022 and then crashed by 87754.24% in 2024.
Castle Biosciences' Deferred Taxes (Quarter) stood at -$8.7 million in 2021, then surged by 99.57% to -$38000.0 in 2022, then plummeted by 521.05% to -$236000.0 in 2023, then crashed by 877.54% to -$2.3 million in 2024, then surged by 105.03% to $116000.0 in 2025.
Its Deferred Taxes stands at $116000.0 for Q3 2025, versus -$4.7 million for Q2 2025 and -$770000.0 for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value